Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.
Vidoni ED, et al. Among authors: wilkins hm.
Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.
Alzheimers Dement. 2021.
PMID: 32715609
Free PMC article.
Clinical Trial.